Helping investors, management teams and other stakeholders successfully steer through M&A transactions and supporting them in the transition phase of the company to the next stage of its journey is always a unique experience and very rewarding.
Felix advises clients on mergers and acquisitions (M&A) in Lincoln International’s Frankfurt office in the firm’s Global Healthcare Group.
Felix takes a proactive, pragmatic and flexible approach to achieve the best possible results for his clients.
Felix brings many years of M&A experience to the role, having held positions most recently as an M&A advisor at EY as part of the Life Sciences, Chemicals and Healthcare sector teams and previously at Siemens where he focused on today’s Siemens Healthineers, the company’s healthcare engineering segment.
Felix holds a master’s degree in business administration and economics from Witten/Herdecke University.
Recent Transactions in Healthcare
Lincoln International advises Memira, a portfolio company of Patricia Industries, in its sale to Bergman Clinics
Lincoln International is pleased to have advised the partners of Scarsdale Vets on the sale to Independent Vetcare, a portfolio company of EQT Partners
Lincoln is pleased to announce that it has advised Aksìa Group SGR on the sale of Lameplast to Tekni-Plex
Lincoln International is pleased to announce that Nelipak Healthcare Packaging, a portfolio company of Mason Wells, has been sold to Kohlberg & Company
Lincoln International is delighted to have represented Handicare Group in its divestment of Puls, a leading distributor of third-party medical consumables and capital goods in Norway and Denmark, to Mediq International
Lincoln International advised on the sale of Nova IVI, India’s second largest provider of fertility treatment services, to TPG Growth
Lincoln International is pleased to have advised Livingbridge on the sale of their minority stake in CREATE Fertility back to the management team
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth